Posted in | News | Semiconductors

EMCORE Introduces the Optiva Series Erbium Doped Fiber Amplifier and pre-Amplifier Modules

EMCORE Corporation, a leading provider of compound semiconductor-based components and subsystems for the fiber optics and space solar power markets, announced today the introduction of the Optiva OTS-2O and OTS-2OP Series Erbium Doped Fiber Amplifier and pre-Amplifier modules, which are designed for a wide variety of extended long-haul signal transport applications.

The Optiva Erbium Doped Fiber Amplifier (EDFA) and pre-Amplifier are ideal building blocks for system integrators to extend fiber optic links beyond 100 km. They are designed to meet the most demanding noise performance requirements of fiber optic communications and control systems, while performing all the functions required of optical amplifiers for system integration. These new EDFA modules are available with optical output powers of 14, 17, 20 and 23 dBm.

Applications for the new Optiva EDFA series include long distance RF and microwave fiber optic communications links, CATV systems and FTTx networks, high-performance supertrunking links, high power distribution networks, sensing and control systems and redundant ring architectures.

The Optiva OTS-2O Series EDFA modules provide input and output optical isolation for stable, low-noise operation. The input and output optical signal power levels are detected for monitoring and control. The input optical signal is amplified with active gain control for a constant output power level, or with active output power control for constant gain mode operation. In the Optiva OTS-2OP EDFA pre-Amplifier, the very low level input optical signal is initially pre-amplified, then amplified with active output power control for constant power mode operation and the output optical signal power levels are detected for monitoring and control.

"The integration of the Optiva OTS-2O and OTS-2OP Series EDFA modules with the Optiva family of 1550 nm fiber optic transport equipment, provides a complete solution that extends the reach of fiber links for a wide range of applications," said Frank Weiss, EMCORE's Vice President of Advanced Systems.

Key features of the new Optiva OTS-2O and OTS-2OP Series EDFA include low noise and low power consumption, standard and optional gain flatness (OTS-2O), along with local and remote monitors and alarms for all critical operating parameters via SNMP and EMCOREView GUI. In addition, the optical output can be split into multiple ports by optional external splitter. The OTS-2O and OTS-2OP Series EDFA fit Optiva 16, 6- and 2-slot enclosures and are RoHS compliant.

EMCORE will debut its new Optiva OTS-2O and OTS-2OP Series EDFA modules at Satellite 2014 at the Walter E. Washington Convention Center in Washington, DC in booth #6089. For more information on EMCORE's Optiva OTS-2O and OTS-2OP Series EDFAs, visit http://www.emcore.com/optiva-edfa.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Emcore Corporation. (2019, February 26). EMCORE Introduces the Optiva Series Erbium Doped Fiber Amplifier and pre-Amplifier Modules. AZoOptics. Retrieved on November 21, 2024 from https://www.azooptics.com/News.aspx?newsID=18800.

  • MLA

    Emcore Corporation. "EMCORE Introduces the Optiva Series Erbium Doped Fiber Amplifier and pre-Amplifier Modules". AZoOptics. 21 November 2024. <https://www.azooptics.com/News.aspx?newsID=18800>.

  • Chicago

    Emcore Corporation. "EMCORE Introduces the Optiva Series Erbium Doped Fiber Amplifier and pre-Amplifier Modules". AZoOptics. https://www.azooptics.com/News.aspx?newsID=18800. (accessed November 21, 2024).

  • Harvard

    Emcore Corporation. 2019. EMCORE Introduces the Optiva Series Erbium Doped Fiber Amplifier and pre-Amplifier Modules. AZoOptics, viewed 21 November 2024, https://www.azooptics.com/News.aspx?newsID=18800.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.